Recently it was demonstrated that IKBKAP mRNA levels are downregulated in FD patients during crisis [91], which emphasizes that treatments that elevate transcription of IKBKAP should be an effective therapy for FD. This evidence concerns the gene ELP1 and Fabry disease.